Jun 14, 2023 by James HalleyWhere Will CRISPR Therapeutics Be in 10 Years?The biotech is part of a revolution in gene-editing therapies.
Jun 13, 2023 by James HalleyWhy Shares of Gracell Biotechnologies Jumped TuesdayGracell climbed higher for a second consecutive day.
Jun 13, 2023 by James HalleyWhy Shares of Surmodics Soared on TuesdayAn analyst upgrade gave the stock a boost.
Jun 13, 2023 by James HalleyWhy Shares of Akoya Biosciences Jumped on TuesdayA rash of insider buying buoyed investor confidence in the medical instrument company.
Jun 12, 2023 by James HalleyWhy Shares of Omeros Dropped on MondayThe clinical-stage biopharmaceutical released trials data through a presentation.
Jun 12, 2023 by James HalleyWhy Shares of Chinook Therapeutics Skyrocketed On MondayThe company, which specializes in treating kidney diseases, agreed to a buyout offer.
Jun 12, 2023 by James HalleyWhy Shares of Vera Therapeutics Are Soaring MondayThe company, which specializes in autoimmune disorders affecting the kidney, benefited from a renewed interest in kidney therapies.
Jun 10, 2023 by James HalleyBetter Long-Term Buy: AbbVie or Novo Nordisk?It's important to factor in a pharmaceutical company's pipeline depth.
Jun 9, 2023 by James HalleyWhy Shares of Arcutis Biotherapeutics Jumped This WeekThe stock got a push when a British medical journal posted trials information on the company's lead product.
Jun 9, 2023 by James HalleyWhy Shares of Cullinan Oncology Jumped This WeekThe company's presentation at a conference got the attention of analysts and investors.
Jun 9, 2023 by James HalleyWhy Shares of AngioDynamics Rose FridayThe medical technology company sold some of its assets to pay down its debt.
Jun 9, 2023 by James HalleyWhy Shares of Oscar Health Soared This WeekThe healthcare insurer continued its upward push this year.
Jun 9, 2023 by James HalleyWhy Shares of AlloVir Jumped This WeekThe company's lead therapy fared well in preventing infections for kidney transplant patients.
Jun 9, 2023 by James Halley2 Top Biotech Stocks to Buy in JuneBoth companies have solid therapy franchises and continue to expand their horizons.
Jun 8, 2023 by James HalleyWhy Shares of Avita Medical Are Soaring ThursdayThe company's lead product gained a big indication approval from the FDA.
Jun 8, 2023 by James HalleyWhy Shares of Innate Pharma Jumped ThursdayThe company's collaboration agreement with Sanofi could soon pay off.
Jun 8, 2023 by James Halley3 Best Marijuana Stocks to Buy in JuneBad news abounds in the cannabis industry, but these companies are healthy enough to thrive.
Jun 7, 2023 by James HalleyWhy Shares of NewAmsterdam Pharma Were Plummeting on WednesdayThe company announced a stock sale to help fund operations.
Jun 7, 2023 by James HalleyWhy Shares of Zai Lab Are Dropping WednesdayThe company released a phase 3 trial regarding a non-small cell lung cancer therapy.
Jun 6, 2023 by James HalleyWhy Shares of Outlook Therapeutics Rose TuesdayThe healthcare stock hit a 52-week high for the second consecutive day.
